According to a recent LinkedIn post from Colossal Biosciences, the company is drawing attention to the conservation needs of the purple frog, a little-known species formally described by scientists only in 2003. The post spotlights the animal’s unusual biology and emphasizes that its ecological uniqueness is considered “worth protecting” by conservation organizations.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights several external groups involved in this work, including the Zoological Society of London’s EDGE of Existence program and the Kerala Forest Research Institute in India. While the post does not reference Colossal’s specific projects or commercial roadmap, the focus on biodiversity preservation may signal continued strategic alignment with wildlife conservation partners, which could support the company’s brand positioning and stakeholder relationships in de-extinction and conservation-related biotech.